Mayne Pharma | MYX - Operating Expenses


Mayne Pharma reported AUD103.54M in Operating Expenses for its fiscal semester ending in June of 2024.





Operating Expenses Change Date
Ansell USD 880.1M 465.65M Dec/2025
Avita Medical AUD 28.02M 1.55M Dec/2025
Cochlear AUD 914.9M 454.8M Dec/2025
CSL USD 5.7B 2.82B Dec/2025
Healius AUD 684.9M 261.2M Dec/2024
Integral Diagnostics AUD 219.16M 66.76M Jun/2024
Medical Developments International AUD 21.61M 11.59M Dec/2025
Nanosonics AUD 93.11M 45.89M Dec/2025
Polynovo AUD 68.22M 1.24M Dec/2025
Ramsay Health Care AUD 8.8B 83.5M Dec/2025
ResMed USD 931.6M 9.09M Mar/2026
Sigma Healthcare AUD 1.68B 174.89M Dec/2024
Sonic Healthcare AUD 4.23B 2.14B Dec/2024
Telix Pharmaceuticals AUD 430.99M 25.59M Jun/2026